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Hydatidiform Mole and Hyperthyroidism
In the past few years many cases have been recorded of tumours arising from tissues lacking an endocrine function yet producing a variety of substances which have a hormonal effect on the patient. Tumours of the bronchus have been shown to contain an adrenocorticotropin' and an antidiuretic substance.2 Sclerosing haemangiomas containing a parathormone-like material,' renal cysts with erythropoetin,4 and sarcomas with insulin-like material' are other examples. Recently it has been shown that tumours of the germinal cells can produce thyroid-stimulating substances.
The thyroid is well known to be responsive to pregnancy. For instance, mild thyrotoxicosis may occur, the basal metabolic rate may be high, the level of protein-bound iodine tends to rise, and the uptake of iodine by the thyroid gland is greater than in the non-pregnant state.' It is possible that the raised basal metabolic rate is due to the increasing oxygen demands of the fetus, the raised protein-bound iodine to an increase in the plasma thyroid-binding globulin produced by oestrogens, and the excess uptake of the iodine to reduction of iodine in the thyroid gland secondary to increased urinary excretion of iodine. But an alternative explanation has recently been advanced. J. M. Hershman and W. R. Starnes7 isolated from normal human placentas a material with thyrotropic activity which they called chorionic thyrotropin.' They showed, moreover, that the average thyrotropic activity in a placenta was the same as in the pituitary gland. The association between pregnancy and thyrotoxicosis extends further, for frank thyrotoxicosis is known to occur in patients with tumours of the placenta.
Probably the first recorded instance of this association was by L. Tisne and his colleagues.8 They showed that in association with hydatidiform mole the uptake of radioiodine by the thyroid gland was higher than in normal pregnancy. and could be accompanied by the clinical signs of thyrotoxicosis. Similar reports9 suggested that the concurrence of these two diseases was more than coincidental, because evacuation of the uterus or treatment of the placental tumour relieved the thyrotoxicosis. Further, the recovery of a thyrotropin from patient's plasma and from the tumour was further proof of a causal relationship. That an association of this kind is not restricted to the female was shown by N Interest has now shifted to identifying the thyroid-stimulating substance in these tumours. Hershman-and H. P. Higgins12 report a further two patients with hydatidiform mole and thyrotoxicosis severe enough to threaten life. Removal of the mole. in both patients cured the thyroid disease, and both have since had normal pregnancies with no disturbance of thyroid function. From one of these patients a thyroid-stimulatory substance was obtained which differed immunologically and chemically from both human pituitary thyrotropin and normal chorionic thyrotropin. This molar thyrotropin, as it has been called, was also unlike long-acting thyroid stimulator (LATS) in its duration of action and its chemical structure, since LATS is now known to be an IgG antibody.
Thus four distinct substances have been isolated which stimulate thyroid activity. Since hydatidiform mole and chorionepithelioma appear to be the source of one of these, we must include these two tumours as parts of the enlarging interface between oncology and endocrinology.
